← Browse by Condition
Medical Condition
laryngeal cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT07209189 Phase 2
Recruiting
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Enrollment
75 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca...
NCT06761937 Phase 1
Recruiting
Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients
Enrollment
30 pts
Location
Netherlands
Sponsor
Erasmus Medical Center